- Primary Yolk Sac Tumor Arising in the Pancreas with Hepatic Metastasis: a Case Report
-
Zhang B, Gao S, Chen Y, Wu Y
- KMID: 984902
- Korean J Radiol.
- 2010 Aug;11(4):472-475.
- doi: 10.3348/kjr.2010.11.4.472
Extragonadal yolk sac tumor (YST) is a relatively rare entity. We describe here the case of an extragonadal YST that occurred in the pancreas with hepatic metastasis in an adult... -
- CITED
-
- Close
- SHARE
-
- Close
- The Physiological Functions and Polymorphisms of Type II Deiodinase
-
Deng Y, Han Y, Gao S, Dong W, Yu Y
- KMID: 2541875
- Endocrinol Metab.
- 2023 Apr;38(2):190-202.
- doi: 10.3803/EnM.2022.1599
Type II deiodinase (DIO2) is thought to provide triiodothyronine (T3) to the nucleus to meet intracellular needs by deiodinating the prohormone thyroxine. DIO2 is expressed widely in many tissues and... -
- CITED
-
- Close
- SHARE
-
- Close
- Inhibition of chromosomal region maintenance 1 suppresses the migration and invasion of glioma cells via inactivation of the STAT3/MMP2 signaling pathway
-
Shan Q, Li S, Cao Q, Yue C, Niu M, Chen X, Shi L, Li H, Gao S, Liang J, Yu R, Liu X
- KMID: 2502501
- Korean J Physiol Pharmacol.
- 2020 May;24(3):193-201.
- doi: 10.4196/kjpp.2020.24.3.193
Chromosomal region maintenance 1 (CRM1) is associated with an adverse prognosis in glioma. We previously reported that CRM1 inhibition suppressed glioma cell proliferation both in vitro and in vivo. In... -
- CITED
-
- Close
- SHARE
-
- Close
- Luteolin Protects Cardiomyocytes Cells against Lipopolysaccharide-Induced Apoptosis and Inflammatory Damage by Modulating Nlrp3
-
Liu Z, Gao S, Bu Y, Zheng X
- KMID: 2526554
- Yonsei Med J.
- 2022 Mar;63(3):220-228.
- doi: 10.3349/ymj.2022.63.3.220
Purpose: In this article, we aimed to investigate the influences of luteolin on inflammatory injury to cardiomyocytes induced by lipopolysaccharide (LPS). Materials and Methods: H9c2 cells were pretreated with different concentrations... -
- CITED
-
- Close
- SHARE
-
- Close
- Growth Inhibitory and Pro-Apoptotic Effects of Hirsuteine in Chronic Myeloid Leukemia Cells through Targeting Sphingosine Kinase 1
-
Gao S, Guo T, Luo S, Zhang Y, Ren Z, Lang X, Hu G, Zuo D, Jia W, Kong D, Yu H, Qiu Y
- KMID: 2534705
- Biomol Ther.
- 2022 Nov;30(6):553-561.
- doi: 10.4062/biomolther.2022.023
Chronic myeloid leukemia (CML) is a slowly progressing hematopoietic cell disorder. Sphingosine kinase 1 (SPHK1) plays established roles in tumor initiation, progression, and chemotherapy resistance in a wide range of... -
- CITED
-
- Close
- SHARE
-
- Close
